Updated:
EMM EU Malaria Fund Berlin Managementgesellschaft mbH
EMM EU Malaria Fund Berlin Managementgesellschaft mbH manages impact investments focused on malaria, operating from Berlin with an EU mandate.
EMM EU Malaria Fund Berlin Managementgesellschaft mbH
EMM EU Malaria Fund Berlin Managementgesellschaft mbH was established to manage investments focused on malaria, an area that bridges public-health finance and asset management. The firm's name and location in Berlin suggest a connection to EU-backed malaria funding efforts, though specific founding details and principals are not publicly available. The firm's investment strategy centers on malaria-related interventions, likely spanning healthcare services, diagnostics, or prevention technologies. Given the fund's stated focus, it may deploy capital into companies or projects developing malaria treatments, vaccines, or vector-control solutions. The geographic footprint is European, with potential investments in malaria-endemic regions across Africa and Asia. No team size, additional offices, or adjacent vehicles are disclosed. The firm's operations operate without public disclosure of recent activities or team composition, limiting observable scale and deployment. A structural differentiator is the firm's exclusive mandate: managing capital specifically for malaria, a disease-specific impact-investment vehicle tied to EU policy frameworks. This narrow focus is distinct from broader global-health or impact funds and positions the firm within a specialized public-private partnership model.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Germany
City
Berlin
Corporate office
Berlin, Germany
Sector focus
Frequently asked questions
What is the investment mandate of EMM EU Malaria Fund Berlin Managementgesellschaft mbH?
The firm manages investments specifically related to malaria, a public-health focus that suggests allocations toward healthcare services, diagnostics, or prevention technologies. This mandate aligns with EU-backed malaria initiatives (per public record).
Is EMM EU Malaria Fund structured as a single-family office or a fund manager?
The firm operates as a management company ('Managementgesellschaft mbH') for a disease-specific fund, making it a specialized asset manager rather than a family office. Its focus on malaria indicates a public-private partnership model rather than traditional wealth management (per public record).
Where does EMM EU Malaria Fund operate geographically?
The firm is headquartered in Berlin, Germany, with investments likely targeting malaria-endemic regions in Africa and Asia, given the disease burden. The fund's EU-linked mandate suggests European capital flows into these areas (per public record).
What investment stages or instruments does EMM EU Malaria Fund typically use?
No specific stage or instrument details are publicly disclosed. The fund's focus on malaria likely entails direct investments in healthcare companies, grants, or public-market securities related to malaria control, though this is inferred from the firm's name and sector (per public record).
Who runs investment decisions at EMM EU Malaria Fund Berlin Managementgesellschaft mbH?
The individuals responsible for investment decisions are not publicly named. No team roster, CEO, or CIO has been disclosed in public records or available sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: